Hexagonal Sodium Yttrium Fluoride Based Green and Blue Emitting Upconversion Phosphors. -Pure hexagonal Na 3x Ln 2-x F 6 (Ln: Y, Nd, Er, Tm, Yb; x = 0.45) phosphor powder samples are synthesized from Ln2O3, Na2CO3, HBr, and HF in H2O (550-540°C, 40 h). As revealed by powder XRD the samples crystallize in the space group P63/m with Z = 1. The samples doped with 18% Yb + 2% Er and 25% Yb + 0.3% Tm show the highest upconversion efficiencies for green and blue emission, respectively. The obtained phosphor materials show no degradation under high-power IR laser excitation. -(KRAEMER*, K. W.; BINER, D.; FREI, G.; GUEDEL, H. U.; HEHLEN, M. P.; LUETHI, S. R.; Chem. Mater. 16 (2004) 7, 1244-1251; Inst. Chem. Biochem., Univ. Bern, CH-3012 Bern, Switz.; Eng.) -W. Pewestorf 26-017
An efficient synthetic approach to construct a fully substituted benzo[1,2-b:4,5-b']difuran (BDF) 2a via base-catalyzed double annulations is presented. Compound 2a can readily undergo Suzuki, Heck, and Sonogashira coupling reactions to afford in good yields a manifold of extended pi-conjugated BDF derivatives, e.g., with pyridine termini (4-6) and with different spacers. These are highly luminescent materials that undergo two reversible one-electron oxidations. Remarkably, their photophysical and electrochemical properties can be largely tuned by methylation or protonation. Consequently, they can function as pH-dependent fluorescence switches. Finally, the observed electronic properties are explained on the basis of density functional theory.
Benzodifuran-functionalised pyrene and anthracene fluorophores 1 and 2 were obtained in reasonable yields. Their single crystal structures, electrochemical, optical absorption, and fluorescence characteristics have been described. They show strong luminescence with high quantum yields of 0.53 for 1 and 0.48 for 2.
The crystal structure of [Rh(phpy)2(bpy)]PF6 (phpyH = 2-phenylpyridine, bpy = 2,2,-bipyridine) is determined and described. Crystallographic data at 100 K: chemical formula C32H24F6N4PRh, orthorhombic crystal system, space group Pbca (No. 61), Z = 8, a = 10.821 (1) A, b = 15.798 (1) A, c = 33.328 (3) A, V= 5697.4 (9) A3. There is one complex cation, i.e. two crystallographically inequivalent phpy ligands, per asymmetric unit. Polarized single-crystal absorption spectra of [Rh(phpy)2(bpy)]PF6 and excitation and site-selective luminescence spectra of [Rh(thpy)2(bpy)]+ and [Rh(thpy)(phpy)(bpy)]+ (thpyH = 2-thienylpyridine) doped into [Rh(phpy)2(bpy)]PF6 are reported and interpreted on the basis of the crystal structure of [Rh(phpy)2(bpy)]PF6. The two lowest-energy excitations of [Rh(phpy)2(bpy)]PF6, and also of [Rh(phpy)2(bpy)]BPh4, [Rh(phpy)2(en)]PF6, and [Rh(phpy)2-(en)]BPh4 (BPh4" = tetraphenylborate anion, en = ethylenediamine), are found in the region between 21 400 and 22 200 cm-1 with an energy splitting ranging from 22 to 242 cm-1. They are assigned to electronic transitions involving the phpy ligands. The third excited state of [Rh(phpy)2(bpy)]PFe lies 967 cm-1 above the first excited state and is ascribed to an analogous transition involving the bpy ligand. The polarization properties of these three lowest-energy transitions and the crystal structure of [Rh(phpy)2(bpy)]PF6 show that the transition moments are parallel to the ligand planes: The bpy transition is short-axis polarized, and the two phpy transitions are oriented approximately parallel to the respective Rh-N(phpy) bonds. It is concluded that the three lowest-energy excited states are essentially 3 * states, localized on the three ligands of the complex. They have a small admixture of the lowest-energy 'drr* excitations through spin-orbit coupling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.